T cells distinguish self from nonself through a combination of molecular recognition, developmental selection, and regulatory controls that balance defense against pathogens with prevention of damage to the host. At the molecular level, each T cell expresses a unique T cell receptor that inspects short peptide fragments presented on major histocompatibility complex molecules. Peter Doherty of the University of Melbourne and Rolf Zinkernagel of the University of Zurich established that T cells recognize peptide bound to MHC, a principle called MHC restriction that underlies how T cells sense whether a peptide originates from host proteins or from foreign organisms. Mark M. Davis at Stanford University has further characterized how T cell receptors can be highly specific yet cross-reactive, enabling recognition of many pathogens while risking potential reaction to similar self-peptides.
T cell development and central tolerance
T cells are educated in the thymus through opposing selection processes. Positive selection favors thymocytes whose receptors can weakly recognize self-MHC, ensuring compatibility with the host’s antigen presentation. Negative selection eliminates cells that bind too strongly to self-peptides. The autoimmune regulator AIRE directs expression of a broad array of tissue-specific antigens in the thymus, and research led by Mark S. Anderson at the University of California San Francisco has shown how AIRE-dependent presentation helps delete self-reactive T cells that otherwise could cause autoimmune disease. Failures in these central mechanisms can leave autoreactive clones in the circulation.
Peripheral mechanisms and clinical consequences
Beyond the thymus, peripheral tolerance limits activation of potentially harmful T cells. Dendritic cells, discovered and characterized by Ralph M. Steinman at Rockefeller University, present antigen with contextual signals from innate immunity. Charles A. Janeway at Yale University articulated the importance of innate pattern recognition for distinguishing pathogenic nonself, and Polly Matzinger at the University of Pennsylvania proposed the danger model emphasizing tissue stress signals. Regulatory T cells, identified by Shimon Sakaguchi at Osaka University, suppress autoreactive responses and maintain homeostasis. Immune checkpoints such as CTLA-4 and PD-1, the clinical relevance of which was demonstrated by James P. Allison at MD Anderson Cancer Center and Tasuku Honjo at Kyoto University, restrain T cell activation; therapeutic blockade of these pathways can unleash anti-tumor immunity but may also precipitate autoimmunity.
Relevance, causes, and broader impacts
The balance between recognition and tolerance explains consequences seen across medicine and society. When discrimination fails, autoimmune diseases and inflammatory tissue damage arise; when recognition is inadequate, chronic infection or cancer persistence can follow. HLA variation among populations influences susceptibility to diseases and compatibility for organ transplantation, so genetic and territorial diversity shapes clinical outcomes and access to matched donors. Environmental exposures such as infections, microbiome composition, and nutritional status modulate danger signals and tolerance thresholds, linking ecological and cultural contexts to immune behavior. Advances in understanding T cell discrimination have enabled vaccines, transplantation strategies, and immunotherapies, but they also require careful consideration of population diversity and the risk of disrupting regulatory mechanisms that evolved to prevent self-damage.